New data finds an experimental cancer treatment is showing major promise.
Our team spoke with the first person to receive a personalized mRNA vaccine for pancreatic cancer at Memorial Sloan Kettering, who has now been cancer-free for six years.
NBC News’ Anne Thompson has a closer look at how it works.